A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality Changhai Hospital, Shanghai, Shanghai Municipality Shanghai Chest Hospital, Shanghai, Shanghai Municipality Shanghai General Hospital, Shanghai, Shanghai Municipality Age range
18 Years – 80 Years
Last updated January 2026